Rapid Epidemiological Analysis of Comorbidities andTreatments as risk factors for COVID-19 in Scotland(REACT-SCOT): a population-based case-control study

Paul M McKeigue; Amanda Weir; Jen Bishop; Stuart McGurnaghan; Sharon Kennedy; David McAllister; Chris Robertson; Rachael Wood; Nazir Lone; Janet Murray; Thomas Caparrotta; Alison Smith-Palmer; David Goldberg; Jim McMenamin; Colin Ramsay; Sharon Hutchinson; Helen M Colhoun.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-20115394

Documentos relacionados

  1. Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.
  2. Inhaled corticosteroids for the treatment of COVID-19.
  3. Real-world effectiveness of steroids in severe COVID-19: a retrospective cohort study.
  4. Age-specific associations between underlying health conditions and hospitalisation, death and in-hospital death among confirmed COVID-19 cases: a multi-country study based on surveillance data, June to December 2020.
  5. Post-COVID Syndrome: The Stranger Ghost of Culprit COVID-19.
  6. Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study.
  7. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
  8. Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): A Real-World Experience.
  9. Clinical and laboratory characteristics of patients hospitalised with COVID-19: clinical outcomes in Abu Dhabi, United Arab Emirates.
  10. The Life of SARS-CoV-2 Inside Cells: Replication-Transcription Complex Assembly and Function.